Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Total Long Term Debt: 2011

  • UNITED THERAPEUTICS's Total Long Term Debt was N/A to $1.1 billion in Q4 2011 from the same period last year, while for Dec 2011 it was $1.1 billion, marking a year-over-year change of. This contributed to the annual value of $1.1 billion for FY2011, which is N/A change from last year.
  • UNITED THERAPEUTICS's Total Long Term Debt amounted to $1.1 billion in Q4 2011.
  • In the past 5 years, UNITED THERAPEUTICS's Total Long Term Debt registered a high of $1.1 billion during Q4 2011, and its lowest value of $1.1 billion during Q4 2011.
  • Moreover, its 1-year median value for Total Long Term Debt was $1.1 billion (2011), whereas its average is $1.1 billion.